BeStock  
Stocks › Biotechnology › JANX

Janux Therapeutics JANX

US equityMarket cap rank #3178Biotechnology
$17.92 +$1.13 (+6.73%)
Pre-market · Oct 8, 8:20 am ET · After hours $18.50 +3.24%
Open$16.52
Prev close$16.79
Day range$16.42 – $18.37
Volume1.21M
Market cap$1.10B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-10.9x
CheapRich

Around its usual level · 46th percentile, 5-year average -16.9x

Price / book1.2x
CheapRich

Near the bottom of its 5-year range · 19th percentile, 5-year average 2.1x

#1643 of 5317 stocks by PB (1 = cheapest)

Price / sales45.6x
CheapRich

Near the bottom of its 5-year range · 4th percentile, 5-year average 326.5x

#4822 of 5146 stocks by PS (1 = cheapest)

P/E over five years

-68x-45x-22x2xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$27.04
Price vs. fair value-33.7%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.18 – 2.11 19% (cheaper than usual) #1643 of 5317 (1 = cheapest)
PE -10.93 -7.76 -16.93 46% (cheaper than usual) –
PS 45.65 58.75 326.49 4% (cheaper than usual) #4822 of 5146 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★★
Fair value estimate$27.04
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on JANX.

Leave a comment

Scroll to Top